{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:46:37Z","timestamp":1792003597575,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ophtha.2007.07.025","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T13:16:46Z","timestamp":1190985406000},"page":"988-992.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Therapeutic Effects of Tacrolimus Ointment for Refractory Ocular Surface Inflammatory Diseases"],"prefix":"10.1016","volume":"115","author":[{"given":"Dai","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kakimaru-Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.07.025_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ophtha.2007.07.025_bib2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ophtha.2007.07.025_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00044011-200626050-00001","article-title":"Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan","volume":"26","author":"Nakagawa","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ophtha.2007.07.025_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.ico.0000127484.46584.f6","article-title":"Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma","volume":"23","author":"Kymionis","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2007.07.025_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2007.07.025_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0151-9638(06)70869-9","article-title":"Topical tacrolimus treatment for ocular cicatricial pemphigoid","volume":"133","author":"Michel","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ophtha.2007.07.025_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.ico.0000214208.14576.1a","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"25","author":"Cheng","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2007.07.025_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","article-title":"Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study","volume":"84","author":"Virtanen","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2007.07.025_bib9","first-page":"305","article-title":"The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits","volume":"42","author":"Fei","year":"2006","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.ophtha.2007.07.025_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.ico.0000114836.13127.45","article-title":"The relation of conjunctival and corneal findings in severe ocular allergies","volume":"23","author":"Tanaka","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2007.07.025_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/0929867043455576","article-title":"Inhibitors of the calcineurin\/NFAT pathway","volume":"11","author":"Martinez-Martinez","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ophtha.2007.07.025_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1016\/j.ophtha.2007.07.025_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00173216","article-title":"The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line","volume":"348","author":"Schwaninger","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ophtha.2007.07.025_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35001102","article-title":"How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis","volume":"403","author":"Glynne","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2007.07.025_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bjp.0707002","article-title":"Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506","volume":"150","author":"Harrison","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ophtha.2007.07.025_bib16","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2007.07.025_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.07.025_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","article-title":"Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment","volume":"113","author":"Vichyanond","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2007.07.025_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-2277.2004.00006.x","article-title":"Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.ophtha.2007.07.025_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-2001-18665","article-title":"FK 506 ointment 0.1%\u2014a new therapeutic option for atopic blepharitis: clinical trial with 14 patients","volume":"218","author":"Mayer","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"suppl","key":"10.1016\/j.ophtha.2007.07.025_bib21","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ophtha.2007.07.025_fr1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0161-6420(91)32272-3","article-title":"Long-term results of keratoepithelioplasty in Mooren's ulcer","volume":"98","author":"Kinoshita","year":"1991","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007008263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007008263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:56:53Z","timestamp":1758981413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007008263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0161642007008263"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.07.025","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Effects of Tacrolimus Ointment for Refractory Ocular Surface Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}